Quick Answer
GOLDENWELL BIOTECH, INC. reported Net Income of -$131.5 thousand for fiscal year 2024.
GOLDENWELL BIOTECH, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$131.5K | -12.0% |
| 2023 | -$117.4K | +88.1% |
| 2022 | -$985.1K | -742.1% |
| 2021 | -$117.0K | -1749.8% |
| 2020 | -$6.3K | -173.6% |
| 2019 | -$2.3K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.0K | -134.6% | -53.0% |
| June 30, 2025 | -$5.2K | -110.5% | +84.8% |
| March 31, 2025 | -$34.4K | -211.0% | -249.0% |
| September 30, 2024 | $23.1K | +165.1% | -53.8% |
| June 30, 2024 | $49.9K | +284.3% | +61.2% |
| March 31, 2024 | $31.0K | +192.2% | +248.9% |
| December 31, 2023 | -$20.8K | +97.7% | +41.3% |
| September 30, 2023 | -$35.4K | -672.4% | -30.7% |
- GOLDENWELL BIOTECH, INC. showed a decrease of -12.0% in Net Income compared to the prior fiscal year.
- Over the 2019–2024 period, GOLDENWELL BIOTECH, INC.’s net income has declined by 5590.1% (from -$2.3 thousand to -$131.5 thousand).
- The most recent figure is from GOLDENWELL BIOTECH, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: